Microvessel density of hepatocellular carcinoma: its relationship with prognosis

被引:103
作者
Sun, HC
Tang, ZY [1 ]
Li, XM
Zhou, YN
Sun, BR
Ma, ZC
机构
[1] Shanghai Med Univ, Liver Canc Inst, Shanghai 200032, Peoples R China
[2] Shanghai Med Univ, Zhong Shan Hosp, Dept Pathol, Shanghai 200032, Peoples R China
关键词
angiogenesis; hepatocellular carcinoma; prognosis; microvessel density;
D O I
10.1007/s004320050296
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To elucidate the relationship between angiogenesis and prognosis after curative resection of hepatocellular carcinoma (HCC). Methods: An immunohistochemical study using anti-CD34 monoclonal antibody was carried out on surgical specimens from 78 HCC patients who had undergone curative resection; microvessel density (MVD) was counted and the overall survival and disease-free survival were analyzed retrospectively. Results: Blood vessels in the tumor were strongly stained by anti-CD34 antibody, but not those in the surrounding liver parenchyma. There were three types of tumor vessels: capillary-like (n = 59), sinusoidlike (n = 16) and mixed-type (n = 3). The median MVD count was 100 per field. The HCC were designated as hypovascular (n = 36) with an MVD count below 100, and hypervascular (n = 42) with an MVD count of 100 or more per field. The 5-year survival and disease-free survival rates were 49.7% and 42.8% respectively, and statistical analysis showed that the MVD level was not correlated with tumor size, capsule status, Edmondson's grade, alpha-fetoprotein level, associated cirrhosis, gamma-glutamyltransferase, and serum HBsAg status. The sinusoid-like tumor vessels appeared more frequently in the more differentiated tumors (P < 0.05). No statistical difference in overall and disease-free survival between different MVD levels and microvessel types was found. Tumor size was the only predicting factor in the entire series. In patients with small HCC (less than or equal to 5 cm, n = 40), 5-year survival and disease-free survival rates were 58.9% and 52.7% respectively, higher than the values in large HCC (39.8% and 32.0% respectively, P < 0.05). The MVD level was an independent predicting factor of disease-free survival, 5-year disease-free survival in the hypovascular group (74.6%) being better than that in the hypervascular group (34.7%, P < 0.05). Conclusions: The MVD level was not related to tumor size, capsule statue, Edmondson's grade, alpha-fetoprotein level, associated cirrhosis, gamma-glutamyltransferase and serum HBsAg status. In the entire series, tumor size was the only factor influencing survival after curative resection. However, in patients with small HCC, the MVD level was an independent factor of disease-free survival. The pathological and clinical implications of different types of tumor vessels in HCC remain to be studied.
引用
收藏
页码:419 / 426
页数:8
相关论文
共 33 条
  • [1] ENDOTHELIAL MARKERS IN MALIGNANT VASCULAR TUMORS OF THE LIVER - SUPERIORITY OF QB-END/10 OVER VONWILLEBRAND-FACTOR AND ULEX EUROPAEUS AGGLUTININ-1
    ANTHONY, PP
    RAMANI, P
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (01) : 29 - 32
  • [2] Araya M, 1997, J SURG ONCOL, V65, P232, DOI 10.1002/(SICI)1096-9098(199708)65:4<232::AID-JSO2>3.0.CO
  • [3] 2-6
  • [4] DNA ploidy study of resected hepatocellular carcinoma in cirrhotic liver
    Balsells, J
    Caragol, I
    Allende, E
    Diaz, I
    Charco, R
    Lazaro, JL
    Murio, E
    Margarit, C
    [J]. JOURNAL OF HEPATOLOGY, 1996, 25 (06) : 854 - 858
  • [5] CHIU ST, 1997, CHIN MED J TAIPEI, V59, P177
  • [6] Enhanced CD34 expression of sinusoid-like vascular endothelial cells in hepatocellular carcinoma
    Cui, SJ
    Hano, H
    Sakata, A
    Harada, T
    Liu, TC
    Takai, S
    Ushigome, S
    [J]. PATHOLOGY INTERNATIONAL, 1996, 46 (10) : 751 - 756
  • [7] Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver
    El-Assal, ON
    Yamanoi, A
    Soda, Y
    Yamaguchi, M
    Igarashi, M
    Yamamoto, A
    Nabika, T
    Nagasue, N
    [J]. HEPATOLOGY, 1998, 27 (06) : 1554 - 1562
  • [8] Folkman J., 1996, CANC MED, V1, P181
  • [9] Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype
    He, B
    Tang, ZY
    Liu, KD
    Zhou, G
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (12) : 763 - 766
  • [10] HOLLINGSWORTH HC, 1995, AM J PATHOL, V147, P33